Skip to main content
. 2022 Apr 28;70:154047. doi: 10.1016/j.jcrc.2022.154047

Table 3.

Clinical outcomes.

Overall cohort (n = 903) VT ≤ 6 mL/kg PBW (n = 294) VT > 6 mL/kg PBW (n = 609) P valuea
Mortality
Mortality at day 28 257 (28.9) 67 (23.1) 190 (31.7) 0.005
Mortality at day 90 313 (37.9) 93 (34.1) 220 (39.8) 0.024
In hospital mortality 300 (36.1) 84 (31.3) 216 (38.3) 0.017
ICU mortality 291 (33.0) 80 (27.9) 211 (35.5) 0.013



Clinical ventilator outcomes
Ventilator free days at day 28, days 2.48 [0.00–16.00] 4.96 [0.00–16.99] 0.96 [0.00–15.96] 0.175
Duration of ventilation, days 16.00 [9.04–28.02] 15.04 [9.52–28.04] 16.00 [9.04–28.00] 0.782
Length of hospital stay in survivors 29.04 [20.04–43.03] 30.00 [19.52–42.54] 29.04 [20.04–43.02] 0.986
Length of ICU stay in survivor 17.04 [11.00–29.00] 16.04 [10.00–28.01] 18.00 [11.01–30.03] 0.405
Successful extubation 528 (58.9) 181 (62.2) 347 (57.4) 0.191
Reintubation 117 (13.1) 37 (12.8) 80 (13.3) 0.917
Tracheostomy 145 (16.2) 47 (16.1) 98 (16.3) 1.000
Pneumothorax 8 (0.9) 2 (0.7) 6 (1.0) 0.971



Extrapulmonary outcomes
Thrombotic event 259 (28.7) 97 (33.0) 162 (26.6) 0.056
Acute kidney injury 403 (44.8) 131 (44.7) 272 (44.8) 1.000
Renal replacement therapy 163 (18.1) 59 (20.1) 104 (17.1) 0.316

Data are median [quartile 25% - quartile 75%] or No (%). Percentages may not total 100 because of rounding.

a

P value is computed comparing patients receiving VT ≤ 6 mL/kg PBW versus VT > 6 mL/kg PBW.